DBA/2N males were used to breed the (CBA/N x DBA/2)FI male (defective) and FI female (normal) mice used in some experiments.
Culture Conditions. Single cell suspensions of mouse thymus or spleen were prepared and cultured by using a microculture adaptation of the Mishell and Dutton method as previously described (19) . Briefly, a total of 1 x 108 cells were cultured in each well of a flat-bottomed microtiter plate (Falcon 3040, Falcon Plastics, Division of BioQuest, Oxnard, Calif.) for periods of 3-4 days in a humidified 5% CO2-95% air atmosphere. Antibody formation against the trinitrophenyl (TNP) determinant was stimulated by the addition of TNPss aminoethylcarbamylmethyl (aecm)s3 Ficoll, TNP-lipopolysaccharide (TNP-LPS), or TNP.Brucella abortus. These antigens appear to be thymic-independent in the newborn as well as the adult mouse (D. E. Mosier. Manuscript in preparation) and their preparation has been described previously (20, 21) . Direct plaque-forming cells (PFC) were assayed against TNP-modified sheep erythrocytes prepared as described by Rittenberg and Pratt (22) . All groups were assayed in triplicate and the data logarithmically transformed to obtain the geometric mean. Data are expressed as the antilog of the geometric mean ×/-the relative standard error (the antilog of the log standard error). Proliferation assays were performed as described previously.
Virus Injection. Mouse thymic virus was obtained by serial passage from a stock maintained by Dr. Wallace Rowe, National Institute of Allergy and Infectious Diseases, National Institutes of Health and donated to us by Dr. Sue Cross. Newborn mice were injected intraperitoneally within 18 h of birth with a 1:10 dilution of a clarified supernate of virus thymus homogenate. Mice were examined when sacrificed 10-14 days later for the gross thymic necrosis associated with virus infection, and any mice not showing this sign were excluded from the experiment.
CytotoxicityAssay. The complement-dependent cytotoxicity assay of Gorer and O'Gorman (23) was used with the modification described by Boyse et al. (24) . Equal 0.05-rnl columns of: (a) antiserum serially diluted; (b) selected rabbit serum diluted 1:15 in anti-Ly tests (25, 26) , or guinea pig serum diluted 1:4 in anti-TL, -Thy 1, and H-2 tests (both complement sources were selected for low cytotoxicity against mouse thymocytes and high complement activity); and (c) cells suspended in medium 199 (Hank's balanced salt solution base) at 5 × 106/ml were incubated at 37°C for 45 rain. Cell viability was assessed by trypan blue exclusion.
Antisera and Immunofluorescence Reagents. The anti-Ly, anti-TL, and anti-Thy 1.2 sera used in this study were obtained from Doctors E. A. Boyse and F.-W. Shen and details of their specificity are presented elsewhere. 2 The anti-H-2 b reagent was obtained from BALB/c AnN female mice which had received both skin grafts and peripheral lymphoid cell suspensions from (BALB/c × C57BL/6N)FI or C57BL/6 female mice. At the dilutions used in these studies, the antiserum does not react with BALB/c, NZB, or B10.D2 mouse thymocytes. The anti-Thy 1.2 serum used for bulk killing of neonatal spleen cell suspensions was a conventional AKR/J anti-C3H/J thymocyte reagent obtained in the ascites form from Dr. I. Zitron and used after absorption with AKR thymocytes and ultracentrifugation at 100,000 g for 20 min.
The immunofluorescence assays employed a polyvalent goat antiserum to mouse immunoglobulin. Antibody from this antiserum was purified by affinity chromatography on a column containing equal amounts of T~, Th, and T~b mouse myeloma proteins. The purified antibody reacted in double diffusion gels with all classes of immunoglobulins and with K but not k chains. Goat antibodies to mouse imrnunoglobulins (anti-mlg) were coupled to fluorescein by reaction with fluorescein isothiocyanate to achieve a molar ratio of fluorescein to protein of 2.5-5.7. Goat antimlg were conjugated with rhodamine by reaction with tetramethylrhodamine isothiocyanate isomer R (lot F6 EHRT 12, BBL) to achieve a rhodamine:protein molar ratio of 3.0. Unconjugated fluorescein or rhodamine were removed by passage over Sephadex G-25 equilibrated with 0.15 M NaCl, pH 7.4. (Pharmacia Fine Chemicals, Piscataway, N. J.) Rhodamine-anti-mlg also was passed over activated charcoal. These two fluorescent reagents are designated fl-anti-mlg and rhanti-mlg, respectively.
Immunofluorescence Assay. The immunofluorescence test used with the antisera to Ly determinants and the details of the antisera specificity are reported elsewhere. 2 A cell suspension containing 1 × 108 cells was prepared in Hanks' MEM containing 10% heat-inactivated fetal calf serum and 0.1% sodium aside, and incubated with the appropriate antisera for 30 rain on ice. The (Table II) . This subpopulation of virus-resistant T cells therefore seems to be increased in suppressor activity while previous studies have shown it to be devoid of most other T-cell functions. The thymus and spleen cells of neonatally mouse thymic virus-infected BDF1 mice were chosen on this basis as a relatively homogenous population for analysis of cell surface phenotype and morphology.
Results

Neonatal
Ly 1, Ly 2, Thy 1, TL, and H-2 Phenotype of Mouse Thymic Virus-Resistant Thymocytes.
The population of cells obtained from the thymuses of BDF1 mice injected as neonates with mouse thymic virus (and demonstrated in parallel experiments to be enriched for suppressor activity) were tested beth by cytotoxicity and immunofluorescence assays for expression of mouse cell surface alloantigens. In each experiment, cytotoxicity assays or immunofluorescence labeling was performed in parallel on age-matched normal thymocytes as well as mouse thymic virus-resistant thymocytes. Susceptibility of the two cell populations to killing or staining by anti-Ly antisera first was assessed. Since C57BL/6 and DBA/2 mice express different Ly alleles, BDF1 cells were susceptible to antiserum of beth allelic specificities. Treatment of normal 12-day old BDF~ thymocytes with anti-Ly 1.1 or anti-Ly 1.2 antiserum and complement resulted in 60-70% cytotoxicity, as did exposure to anti-Ly 2.1 or anti-Ly 2.2. Fig. 2 shows representative cytotoxicity data from one of four replicate experiments by using the anti-Ly 1.1 or anti-Ly 2.1 reagents. By contrast, between 20 and 40% of thymocytes from virus-infected mice were susceptible to lysis either by anti-Ly 1.1 (or 1.2) or by anti-Ly 2.1 (or 2.2) antiserum (Fig. 2) . The reduced sensitivity of virus-resistant thymocytes to anti-Ly 1 or anti-Ly 2 killing suggests that this subpopulation has either fewer cells expressing Ly antigens or that the amount of Ly antigen expression per cell is substantially reduced. When normal or virus-resistant cells were exposed simultaneously to both anti-Ly 1.1 and antiLy 1.2 antiserum, more than 80% of beth cell populations were susceptible to lysis (Fig. 4) . The same finding was obtained with simultaneous killing with anti-Ly 2.1 and 2.2 (data not shown). These data lead to the tentative conclusion that normal and virus-resistant thymocytes both are Ly 1-and Ly 2-positive although the absolute amount of Ly antigen expressed per cell seems to be reduced in the virus-resistant subpopulation. This conclusion was confirmed directly by two indirect immunofluorescence studies, one of which is shown in Table III . Normal thymocytes or virus-resistant thymocytes were exposed to anti-Ly antisera, washed, and subsequently treated with a fluorescein-or rhodamine-conjugated anti-mIg reagent. Such treatment demonstrated that more than 90% of both cell populations could be stained with anti-Ly 1, 2, or 3. Cells were stained with anti-Ly 1 and fluorescein-anti-mIg followed by anti-Ly 2 (or 3) and rhedamine-anti-mIg to determine if both Ly determinants were present on a single cell (as would be inferred from the high percentage of cells positive with either reagent). Such double staining experiments were performed (Table III) and directly confirmed the presence of Ly 1, 2, and 3 determinants (with a somewhat less intense staining then controls) on virus-resistant thymocytes. The Ly phenotype of that population and the suppressor cells contained within it is therefore Ly 1 +, Ly 2,3 +. Treatment of the same two cell populations with anti-TL, anti-Thy 1.2, and anti-H-2 b antisera and assessment of quantitative cytotoxicity (Figs. 3 and 4) led to the conclusion that the mouse thymic virus-resistant cells were less susceptible to killing with anti-TL and anti-Thy 1.2 sera and more susceptible to killing with anti-H-2 b serum than were normal thymocytes. We would infer that the altered susceptibility to these antisera is correlated with an altered expression of the antigens at the single cell level, but such data are consistent also with population shifts in antigen expression. These experiments, taken together, suggest that the suppressor function which we have studied is a property of cells within a subpopulation of cortical thyrnocytes with the following surface antigen phenotype: Ly I +, Ly 2, 3 +, TL +, Thy 1 + $, H-2 + ~.
Size and Distribution of Mouse Thymic Virus-Resistant Suppressor T Cells.
Thymocytes from normal or virus-injected 10-to 13-day old BDF1 mice were analyzed for size and DNA content by using rapid-flow cytofluorimetry. Individual thymic lobes also were prepared for light and electron microscopy. The 5% of thymocytes surviving neonatal infection with mouse thymic virus were characterized by a larger size, greater DNA content by acridine orange staining (Fig. 5) , and a localization to the subcapsular outer cortex of the thymus. This subpopulation represents a minor fraction of cells present in the normal thymus and thus seems to have been selected for rather than induced by the cytolytic virus infection. From its size and high DNA content the virusresistent subpopulation is rapidly dividing with many cells in late S or G2 phases of the cell cycle.
The Mechanism of Action of Neonatal Suppressor T Cells. The final set of experiments to be presented here concern the mechanism of the suppression of antibody formation induced by the cells characterized above. These experiments were designed to decide between two alternative modes of suppression; the first would be a reduction in the number of B cells initially triggered by a Tindependent antigen (TNP-Ficoll), and the second would be a regulation of B- cell differentiation or proliferation. The suppressor cells induced by concanavalin A treatment of adult spleen cells seem to act by the latter mechanism (27) and limit the burst size of each B-cell clone. An experiment designed to determine the number of adult splenic B cells triggered under limiting conditions by TNP-Ficoll in the presence or absence of neonatal suppressor cells is depicted in Fig. 6 . This experiment is predicated on the finding that (CBA/N x DBA/2)F1 male spleen cells have an X-linked defect that is limited to their B cells and totally precludes any TNP-Ficoll response (28) (29) (30) . Such defective F1 male mice have no known T-cell abnormalities including no known difference in suppressor cell function (30) subpopulation of cells, but splenic neonatal suppressor T cells were not analyzed in detail for their surface phenotype because they represent such a small fraction of cells in the spleen (even in neonatally mouse thyrnic virus-infected mice). The method used to yield a relatively pure, homogenous subpopulation of thyrnocytes was neonatal infection with mouse thymic virus, an agent previously shown to produce a cytolytic infection of the thymus 7-10 days after injection (15) . The 5% of outer cortical thymocytes resistant to the virus were demonstrated to: (a) have greater suppressor activity than cells from intact thymuses, (b) have a Ly 1 +, 2,3 +, TL +, Thy 1 + ~, H-2 + ~ surface alloantigen phenotype; and (c) to be large cells with a greater than average DNA content. From this data we would suggest that the suppressor activity found in neonatal T cells (both in the thymus and probably in the spleen) is a property of large, rapidly dividing cells localized in the outer cortex of the thymus and, by inference, a similar population of cells in the spleen. This inference is based on the absence of T lymphocytes with high Thy 1 expression in the T-dependent areas of splenic lymphoid follicles after neonatal mouse thymic virus infection despite an increase in anti-Thy 1 sensitive suppressor activity. Although we were unable to directly test the Ly phenotype of the splenic suppressor T cell, we also would infer that it is Ly 1 ÷, Ly 2,3+ as is the suppressor cell found in the thymus. A population of thymocytes with similar phenotype, size, and localization has been described (31) . On the basis of early incorporation of [3H]thymidine after topical labeling, this cell is assumed to be rapidly dividing and present in the subcapsular region. It has been suggested that such cells are precursors for more mature T lymphocytes, but it would seem inappropriate to call a cell expressing at least two differentiated functions, suppression, and augmentation of a graftversus-host reaction, immature. If identical cells are found in the spleen, as the presence of suppressor activity would suggest, then such cells must have emigrated from the thymic cortex or have undergone partial differentiation in a nonthymic environment (32) . The finding of T cells capable of suppressing B-cell activation in the spleens of nude mice (33) provides some support for the latter concept.
The suppressor T cells found in the thymus and spleen of neonatal mice seem to differ from T cells capable of suppressing immune response in adult animals. Most authors (7) (8) (9) (10) (11) (12) (13) We have argued previously that neonatal suppressor T cells must directly suppress adult B cells since thymus-independent responses are subject to suppression. This interpretation is strengthened by the experiments depicted in Figs. 6 and 7, which strongly suggest that neonatal suppressor T cells directly react with precursor B cells and prevent antigen-induced differentiation into antibody-forming cells. The data do not exclude, however, an indirect mechanism of suppression mediated, for example, via macrophages or another T-cell subpopulation which has the same phenotype as the T cells which initiate suppression. If B cells are directly subject to suppression, then neonatal suppressor T cells stand in contrast to adult suppressor systems (11) where T cells seems to be the targets of suppressive phenomena. The characterization of the suppressive subpopulation in the thymus suggests one intriguing mechanism for suppression for which we can adduce some very indirect evidence. It has been reported that neonatal thymocytes react by proliferation when confronted with irradiated or mitomycin-treated syngeneic adult spleen cells, generating what has been termed an isogeneic lymphocyte reaction (34) . Furthermore, it was shown that the target cells were mature B cells (35) . In our experience, this phenomenon is limited to a few strains (notably, CBA) and is quite weak compared to an allogeneic reaction; nevertheless, the possibility exists that cells early in the T-cell lineage (which might be expected to be present in large numbers in the early neonatal period) are not self-tolerant and express autoreactivity directed towards antigens which are predominantly expressed on B cells. The crucial prediction of this model is that at least some members of the T-cell subpopulation we have studied express self-reactivity which can be confirmed in a system other than suppression of antibody synthesis.
These experiments emphasize one practical point for those studying B-cell function in newborn animals; specifically, the suppressor T cells we have studied express very low amounts of the Thy 1 antigen and therefore are difficult to eliminate by using standard protocols for anti-Thy I and complement treatment. Unless depletion of suppressor activity is used as a monitor for abolition of T-cell function, we would suggest that experiments viewing the activity of purified neonatal B cells be interpreted with caution. 
Summary
